diatrizoate sodium · Ge Healthcare · NDA 009561, 011386, 016403
Hypaque
Earliest generic entry, as listed · earliest of 6 marketed strengths
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 6
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 009561 · 001 · discontinued | injectable, injection | 50% | open |
| 009561 · 003 · discontinued | injectable, injection | 25% | open |
| 011386 · 001 · discontinued | for solution, oral, rectal | 100% | open |
| 011386 · 003 · discontinued | solution, oral, rectal | 40% | open |
| 016403 · 001 · discontinued | injectable, injection | 60% | open |
| 016403 · 002 · discontinued | injectable, injection | 30% | open |